Abiopharma

Gilead Sciences Announces Third Quarter 2025 Financial Results

New Form 6-K - MOLECULAR PARTNERS AG Filed: 2025-10-30 AccNo: 0001745114-25-000037 Size: 312 KB

MindMed to Report Q3 2025 Financial Results on November 6, 2025

Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Celldex Announces Initial Positive Results from Phase 1 Trial of CDX-622 Demonstrating Favorable Safety and PK Profile and Sustained Mast Cell Inhibition

Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy

Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call

Arcus Biosciences Announces Commencement of Public Offering of Common Stock

Travere Therapeutics Reports Third Quarter 2025 Financial Results

Ligand to Participate in November Investor Conferences

GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market

New Form 6-K - Genfit S.A. Filed: 2025-10-30 AccNo: 0001171843-25-006830 Size: 52 KB

(97% Neutral) Lite Strategy, Inc. (MEIP) Announces Business Combination

📋 WERNER ROBERT F. (Officer) plans to sell 1K shares of Twist Bioscience Corp (at $31.44 each, total $32K) Filed: Oct 30, 2025 | ID: 006620

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025